Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment.

Kim TG, Byamba D, Wu WH, Lee MG.

Exp Dermatol. 2011 Oct;20(10):855-7. doi: 10.1111/j.1600-0625.2011.01343.x.

PMID:
21824198
2.

Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.

Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, Catron D, Buchanan ME, Müller A, deWaal Malefyt R, Deng G, Orozco R, Ruzicka T, Lehmann P, Lebecque S, Caux C, Zlotnik A.

J Immunol. 2000 Jun 15;164(12):6621-32.

3.

Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells.

Hirata T, Osuga Y, Takamura M, Kodama A, Hirota Y, Koga K, Yoshino O, Harada M, Takemura Y, Yano T, Taketani Y.

Endocrinology. 2010 Nov;151(11):5468-76. doi: 10.1210/en.2010-0398.

PMID:
20881253
4.

Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis.

Nakayama T, Fujisawa R, Yamada H, Horikawa T, Kawasaki H, Hieshima K, Izawa D, Fujiie S, Tezuka T, Yoshie O.

Int Immunol. 2001 Jan;13(1):95-103.

PMID:
11133838
5.

CCL20 produced in the cytokine network of rheumatoid arthritis recruits CCR6+ mononuclear cells and enhances the production of IL-6.

Tanida S, Yoshitomi H, Nishitani K, Ishikawa M, Kitaori T, Ito H, Nakamura T.

Cytokine. 2009 Aug;47(2):112-8. doi: 10.1016/j.cyto.2009.05.009.

PMID:
19535263
6.

CCL20 and β-defensin-2 induce arrest of human Th17 cells on inflamed endothelium in vitro under flow conditions.

Ghannam S, Dejou C, Pedretti N, Giot JP, Dorgham K, Boukhaddaoui H, Deleuze V, Bernard FX, Jorgensen C, Yssel H, Pène J.

J Immunol. 2011 Feb 1;186(3):1411-20. doi: 10.4049/jimmunol.1000597.

7.
8.

Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.

Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, Yamaguchi T, Nomura T, Ito H, Nakamura T, Sakaguchi N, Sakaguchi S.

J Exp Med. 2007 Nov 26;204(12):2803-12.

9.

Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.

Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, Skorcheva I, Purdy D, Fitch E, Iordanov M, Blauvelt A.

J Invest Dermatol. 2009 Sep;129(9):2175-83. doi: 10.1038/jid.2009.65.

10.

IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.

Miyagaki T, Sugaya M, Suga H, Kamata M, Ohmatsu H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S.

Clin Cancer Res. 2011 Dec 15;17(24):7529-38. doi: 10.1158/1078-0432.CCR-11-1192.

11.

Up-regulation of CC chemokine ligand 20 and its receptor CCR6 in the lesional skin of early systemic sclerosis.

Tao J, Li L, Tan Z, Li Y, Yang J, Tian F, Wang L, Ren Y, Xu G, He X, Shen G, Tu Y.

Eur J Dermatol. 2011 Sep-Oct;21(5):731-6. doi: 10.1684/ejd.2011.1469.

PMID:
21742595
12.

Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.

Li Q, Laumonnier Y, Syrovets T, Simmet T.

Acta Biochim Biophys Sin (Shanghai). 2013 Jul;45(7):593-600. doi: 10.1093/abbs/gmt049.

PMID:
23681234
13.

Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes.

Kanda N, Shibata S, Tada Y, Nashiro K, Tamaki K, Watanabe S.

Eur J Immunol. 2009 Apr;39(4):996-1006. doi: 10.1002/eji.200838852.

14.

[Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma].

Chang X, Wang L, Zang M, Rong W, Wu Z, Liu L, Du J, Liu J, Wu J, Qu C.

Zhonghua Zhong Liu Za Zhi. 2015 Jan;37(1):5-10. Chinese.

PMID:
25877311
15.

Specific binding and chemotactic activity of mBD4 and its functional orthologue hBD2 to CCR6-expressing cells.

Röhrl J, Yang D, Oppenheim JJ, Hehlgans T.

J Biol Chem. 2010 Mar 5;285(10):7028-34. doi: 10.1074/jbc.M109.091090.

16.

Evidence for a cross-talk between human neutrophils and Th17 cells.

Pelletier M, Maggi L, Micheletti A, Lazzeri E, Tamassia N, Costantini C, Cosmi L, Lunardi C, Annunziato F, Romagnani S, Cassatella MA.

Blood. 2010 Jan 14;115(2):335-43. doi: 10.1182/blood-2009-04-216085.

17.

Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.

Kirshberg S, Izhar U, Amir G, Demma J, Vernea F, Beider K, Shlomai Z, Wald H, Zamir G, Shapira OM, Peled A, Wald O.

PLoS One. 2011;6(9):e24856. doi: 10.1371/journal.pone.0024856.

18.

Preferential recruitment of Th17 cells to cervical cancer via CCR6-CCL20 pathway.

Yu Q, Lou XM, He Y.

PLoS One. 2015 Mar 13;10(3):e0120855. doi: 10.1371/journal.pone.0120855.

19.

Chemokine receptors in the pathogenesis and therapy of psoriasis.

Mabuchi T, Chang TW, Quinter S, Hwang ST.

J Dermatol Sci. 2012 Jan;65(1):4-11. doi: 10.1016/j.jdermsci.2011.11.007. Review.

PMID:
22177422
20.

Supplemental Content

Support Center